Drug discovery

#Drug discovery #Small molecules #Webinar

Webinar: Reduce small molecule discovery timelines to under two years

Join this free webinar, hosted by DDW, to learn how Evotec is planning to shorten timelines for small molecule drug discovery projects.   The webinar will take place on 10 November, 8am PST / 11am EST / 4PM GMT / 5PM CET. Using its ‘Every Compound… Read More

Webinar date:
Supported by Evotec
#News

#Case study #Drug discovery #JAK inhibitor #Molecular dynamics #Proteins

Case study: Identifying ‘new’, active ligands for TYK2

A new Case Study is now available to download from Cresset. In this Case Study, the authors test the predictive abilities of Free Energy Perturbation (FEP) to arrive at accurate binding free energies for ‘new’ ligand suggestions within the TYK2 system. Computational methods used include: Molecular Dynamics (MD) Water… Read More

#News

#Drug discovery #JAK inhibitor #Molecular dynamics #Proteins

A Free Energy Perturbation (FEP) study: Identifying ‘new’, active ligands for TYK2

In this Case Study, we test the predictive abilities of Free Energy Perturbation (FEP) to arrive at accurate binding free energies for ‘new’ ligand suggestions within the TYK2 system. Computational methods used include: Molecular Dynamics (MD) Water analysis solving the Ornstein-Zernike equation (3D-RISM) Alignment of ligands for FEP (Conformation Hunt… Read More

#Case Studies #Resources

#AI / data analytics / healthtech / informatics #Automation #Drug discovery #Organoids #Webinar

How automation and AI enable reliable, scalable models

Hosted by Drug Discovery World and supported by Galatek, this webinar explores how automation and AI enable reliable, scalable models by standardising organoid workflows. Organoids have emerged as powerful in vitro models in disease modelling, drug screening, and regenerative medicine, but their complexity introduces major workflow… Read More

Webinar date:
Supported by Galatek
#News

#Cancer research #Drug discovery

eBook – Go Beyond 2D – Unlock the Full Potential of Spheroid Models in Research

3D spheroid models and live-cell analysis – powerful tools transforming drug discovery and cancer science! Download the eBook to learn: How real-time imaging unlocks deeper insights Discover why 3D models outperform traditional cultures How to create more reliable, clinically relevant cancer models Download now and accelerate your breakthroughs.  … Read More

Antibodies
#Biologics #Drug discovery #eBook #Thermal stability testing

Free resource: Your guide to faster, smarter biologics testing

Thermal stability testing is essential in biotherapeutic development—ensuring safety, efficacy, and shelf-life. It also helps predict aggregation and guides formulation and storage decisions. A new eBook ‘Thermal Stability Technology Selection Guide for Biotherapeutic Drug Development’ is now available to download for free from Waters / TA Instruments. Read this… Read More

#News

#Biologics #Drug discovery #eBook #Thermal stability testing

Your Guide to Faster, Smarter Biologics Testing

Thermal stability testing is essential in biotherapeutic development—ensuring safety, efficacy, and shelf-life. It also helps predict aggregation and guides formulation and storage decisions. Read this eBook to learn: Core techniques used in today’s labs Pros and cons of each method How to choose the right solution for your workflow Real-world… Read More

#eBooks #Resources

#Drug discovery #Immunology #Vaccines #Virology

eBook – Accelerating drug discovery with rational design: Reducing time, cost, and risk with cryo-EM

This eBook highlights recent examples of how cryo-EM and structural insights are being used across various therapeutic modalities to advance drug discovery pipelines. Structure-based drugs have two times the rate of clinical success at 50% of preclinical time and cost. Download this eBook to see the impact of cryo-EM on:… Read More

#eBooks

Human brain
#Artificial intelligence (AI) #Automation #Deep learning #Drug discovery #eBook #Machine learning

eBook: AI – Advancing drug discovery and development

Over the last few years artificial intelligence (AI) has emerged as a key trend and an important area for investment in drug discovery, whether in preclinical research workflows, clinical trial design or regulation. “AI is evolving faster than any other lab technology with new models and… Read More

#News

eBook: AI – Advancing drug discovery and development
#Artificial intelligence (AI) #Automation #Deep learning #Drug discovery #eBook #Machine learning

AI – Advancing drug discovery and development

Over the last few years artificial intelligence (AI) has emerged as a key trend and an important area for investment in drug discovery, whether in preclinical research workflows, clinical trial design or regulation.

#DDW eBooks #Intelligence

London, UK
#DDW Turning Science into Business Symposium #Drug discovery #Events #The Francis Crick Institute

Drug discovery expert shares insight on driving therapeutic discoveries

DDW is delighted to welcome Dr Cathy Tralau-Stewart, Executive Director of The Milner Therapeutics Institute, University of Cambridge to the expert speaker line-up at the DDW Turning Science into Business Symposium. The event will take place at the Francis Crick Institute in London on Tuesday… Read More

#News

#Artificial intelligence (AI) #Drug discovery

AI – Advancing drug discovery and development

Over the last few years artificial intelligence (AI) has emerged as a key trend and an important area for investment in drug discovery, whether in preclinical research workflows, clinical trial design or regulation. This eBook, sponsored by BioIVT, explores the latest AI developments impacting drug discovery, the research areas most… Read More

#DDW eBooks

Medical laboratory
#Antibody drug conjugate (ADC) #Drug discovery #India

Globalising ADC development in the US and beyond

Srivats Rajagopal explores the growth of the antibody-body conjugate (ADC) market, development trends and why innovators are turning towards India. The ADC field has reached an inflection point. In 2022, Enhertu, Kadcyla, and Trodelvy together accounted for more than $4 billion of the $4.7 billion in global ADC revenues, and… Read More

#Exclusive Content

#Drug discovery

Getting Started Guide – Oxford Nanopore sequencing solutions for biopharma

Discover sequencing solutions that can be applied from biomarker discovery through to final product quality control (QC) testing, consolidating multiple legacy assays with one platform — and enabling faster, more confident decision-making. In this new getting started guide, you will:  Find out how Oxford Nanopore sequencing delivers the multiomic insight… Read More

#Guides

#AI / data analytics / healthtech / informatics #Biomarkers #Drug discovery #Personalised medicine #Webinar

Register now: Innovative AI software solutions driving biomarker research

Biomarker discovery and validation are critical for advancing personalised medicine and improving therapeutic outcomes. However, the complexity of high-throughput assays and image-based analyses presents significant challenges in extracting meaningful insights efficiently. Taking place on 23 October at 4pm BST, this webinar, hosted by DDW and supported by Danaher Life… Read More

Webinar date:
Supported by Danaher
#News

Tower Bridge, London
#DDW Turning Science into Business Symposium #Drug discovery #Events #The Francis Crick Institute

Neuroscience expert to speak at DDW Symposium

Join DDW Editor Reece Armstrong and an expert line-up at the DDW Turning Science into Business Symposium at the Francis Crick Institute in London on Tuesday 4 November. This free half-day event will feature six in-depth presentations from industry experts, a panel discussion examining new… Read More

#News